In one aspect, the invention relates to sulfone compounds which are useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurological and psychiatric disorders or other disease state associated with glutamate dysfunction.
在一个方面,本发明涉及用作代谢型谷
氨酸受体亚型4(mGluR4)的变构剂/正变构调节剂的磺酮化合物;制备该化合物的合成方法;包含该化合物的制药组合物;以及使用该化合物的方法,例如,用于治疗神经系统和精神疾病或与谷
氨酸功能障碍相关的其他疾病状态。